Christian Wülfing

3.7k total citations · 1 hit paper
113 papers, 1.9k citations indexed

About

Christian Wülfing is a scholar working on Surgery, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Christian Wülfing has authored 113 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 53 papers in Surgery, 46 papers in Pulmonary and Respiratory Medicine and 21 papers in Oncology. Recurrent topics in Christian Wülfing's work include Bladder and Urothelial Cancer Treatments (26 papers), Testicular diseases and treatments (22 papers) and Prostate Cancer Treatment and Research (18 papers). Christian Wülfing is often cited by papers focused on Bladder and Urothelial Cancer Treatments (26 papers), Testicular diseases and treatments (22 papers) and Prostate Cancer Treatment and Research (18 papers). Christian Wülfing collaborates with scholars based in Germany, United States and France. Christian Wülfing's co-authors include Elke Eltze, L. Hertle, P Wülfing, Ludwig Kiesel, Christian Kersting, W. Böcker, Klaus‐Peter Dieckmann, Edwin Herrmann, Marc‐Oliver Grimm and Susan Feyerabend and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Christian Wülfing

103 papers receiving 1.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Cabazitaxel versus Abiraterone or Enzalutamide in Metastatic Prostate Cancer

2019 377 citations Ronald de Wit, Johann S. de Bono et al. New England Journal of Medicine profile →

Peers

Countries citing papers authored by Christian Wülfing

Since Specialization

Citations

This map shows the geographic impact of Christian Wülfing's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christian Wülfing with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christian Wülfing more than expected).

Fields of papers citing papers by Christian Wülfing

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christian Wülfing. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christian Wülfing. The network helps show where Christian Wülfing may publish in the future.

Co-authorship network of co-authors of Christian Wülfing

This figure shows the co-authorship network connecting the top 25 collaborators of Christian Wülfing. A scholar is included among the top collaborators of Christian Wülfing based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christian Wülfing. Christian Wülfing is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Using ChatGPT-4 for Lay Summarization in Prostate Cancer Research to Advance Patient-Centered Communication: Large-Scale Generative AI Performance Evaluation 2025 ·Journal of Medical Internet Research ·Emily Rinderknecht, (unknown), (unknown), (unknown), (unknown), (unknown), Johannes Breyer, (unknown), Roman Mayr, Christian Gilfrich, Maximilian Burger, (unknown), Hendrik Borgmann, Christian Wülfing, Axel S. Merseburger, Maximilian Haas, Matthias May	0
2	Serum Levels of MicroRNA-371a-3p for Predicting the Histology of Postchemotherapy Residual Masses of Germ Cell Tumours 2024 ·European Urology Focus ·Klaus‐Peter Dieckmann, (unknown), Armin Soave, (unknown), Tim Nestler, Cord Matthies, Julia Heinzelbecker, Alexander Winter, Axel Heidenreich, (unknown), (unknown), (unknown), Christian Wülfing, Pia Paffenholz, Gazanfer Belge	4
3	Influence of Prostate Cancer on Thulium Vapoenucleation of the Prostate—A Multicentre Analysis 2023 ·Journal of Clinical Medicine ·(unknown), Christopher Netsch, Benedikt Becker, Christian Wülfing, Petra Anheuser, Oliver Engel, Andreas J. Gross, Clemens M. Rosenbaum	0
4	Tertiary Syphilitic Gumma Mimicking Testicular Neoplasms 2023 ·Cureus ·(unknown), (unknown), (unknown), Christian Wülfing, Klaus‐Peter Dieckmann	1
5	Age and ECOG Performance Status as Predictors of Survival of Patients with Upper Urinary Tract Urothelial Carcinoma Undergoing Radical Nephroureterectomy 2022 ·Urologia Internationalis ·Lennert Eismann, (unknown), Alexander Büchner, Jozefina Casuscelli, Yannic Volz, Philipp Weinhold, Christian Wülfing, Raphaela Waidelich, Christian G. Stief, Boris Schlenker, Severin Rodler	0
6	Testicular germ cell tumour arising 15 years after radiotherapy with 18 Gy for germ cell neoplasia in situ 2022 ·Strahlentherapie und Onkologie ·Klaus‐Peter Dieckmann, Silke Tribius, (unknown), Andrea Salzbrunn, Kathrein von Kopylow, (unknown), Christian Wülfing	2
7	The Impact of Fluorescence in situ Hybridization on the Staging of Upper Tract Urothelial Carcinoma 2021 ·Urologia Internationalis ·Lennert Eismann, Jan‐Niclas Mumm, (unknown), Christian Wülfing, Ruth Knüchel‐Clarke, Jozefina Casuscelli, Raphaela Waidelich, Christian G. Stief, Boris Schlenker, Severin Rodler	4
8	614P Circulating tumor cell (CTC) morphologic sub-types present prior to treatment in the CARD trial identify therapy resistance 2021 ·Annals of Oncology ·Johann S. de Bono, Klaus Pantel, Eleni Efstathiou, Cora N. Sternberg, D. Castellano Gauna, Karim Fizazi, Bertrand Tombal, Christian Wülfing, Joseph D. Schonhoft, (unknown), (unknown), (unknown), Ayse Ӧzatılgan, Christine Geffriaud-Ricouard, Sandrine Macé, Ronald de Wit	2
9	High Expression of microRNA-371a-3p in Cystic Fluid of Post-Chemotherapy Teratoma with Concurrent Normal Serum Levels in Patients with Non-Seminomatous Testicular Germ Cell Tumours 2020 ·Urologia Internationalis ·Klaus‐Peter Dieckmann, (unknown), Petra Anheuser, (unknown), Florian Viehweger, Christian Wülfing, Gazanfer Belge	7
10	Cabazitaxel versus Abiraterone or Enzalutamide in Metastatic Prostate Cancer breakdown → 2019 ·New England Journal of Medicine ·Ronald de Wit, Johann S. de Bono, Cora N. Sternberg, Karim Fizazi, Bertrand Tombal, Christian Wülfing, Gero Kramer, Jean‐Christophe Eymard, Aristotelis Bamias, Joan Carles, Roberto Iacovelli, Bohuslav Melichar, Ásgerður Sverrisdóttir, Christine Théodore, Susan Feyerabend, Carole Hélissey, Ayse Ӧzatılgan, Christine Geffriaud-Ricouard, Daniel Castellano	377
11	Gender-Specific Variations in Professional and Personal Aspects among Senior Urology Physicians at German Centers: Results of a Web-Based Survey 2019 ·Urologia Internationalis ·(unknown), Ingmar Wolff, Johannes Bründl, Maximilian C. Kriegmair, (unknown), Christian Wülfing, Maximilian Burger, Matthias May, (unknown)	4
12	Serum Levels of MicroRNA371a-3p: A Highly Sensitive Tool for Diagnosing and Staging Testicular Germ Cell Tumours: A Clinical Case Series 2017 ·Urologia Internationalis ·Petra Anheuser, Arlo Radtke, Christian Wülfing, Jennifer Kranz, Gazanfer Belge, Klaus‐Peter Dieckmann	25
13	Phase II study to assess the efficacy, safety and tolerability of the mitotic spindle kinesin inhibitor AZD4877 in patients with recurrent advanced urothelial cancer 2013 ·Investigational New Drugs ·Robert J. Jones, Jacqueline Vuky, Tony Elliott, Graham M. Mead, José Ángel Arranz, John Chester, Simon Chowdhury, Arkadiusz Z. Dudek, (unknown), Marc‐Oliver Grimm, Jürgen E. Gschwend, Christian Wülfing, Peter Albers, Jianguo Li, Anna Osmukhina, Jeffrey Skolnik, Gary R. Hudes	34
14	Multimodality treatment paradigms for renal cell carcinoma: surgery versus targeted agents 2009 ·Expert Review of Anticancer Therapy ·Thomas Köpke, (unknown), Christian Wülfing, Arne Tiemann, L. Hertle, Edwin Herrmann	3
15	The prognostic impact of pelvic lymph node metastasis and lymphovascular invasion on bladder cancer 2008 ·International Journal of Urology ·Edwin Herrmann, (unknown), Arndt van Ophoven, (unknown), Christian Bolenz, L. Hertle, Christian Wülfing	12
16	Histologic Subtype of Metastatic Renal Cell Carcinoma Predicts Response to Combined Immunochemotherapy with Interleukin 2, Interferon α and 5-Fluorouracil 2006 ·European Urology ·Edwin Herrmann, Olaf Anselm Brinkmann, (unknown), (unknown), Thomas Köpke, Martin Bögemann, L. Hertle, Christian Wülfing	19
17	In-vivo activity of ABT-627, a selective Endothelin-A-receptor antagonist, in bladder cancer xenograft tumors 2005 ·Cancer Research ·Christian Wülfing, Arne Tiemann, Thorsten Persigehl, P Wülfing, Elke Eltze, L. Hertle, Christoph Bremer	3
18	Targeting the Endothelin-A-receptor inhibits breast carcinoma growth in vivo 2005 ·Cancer Research ·P Wülfing, Thorsten Persigehl, Martin Götte, Volker Meyer, Christian Wülfing, Christian Kersting, Barbara Sonntag, Ludwig Kiesel, Christoph Bremer	2
19	Cox-2 and Her2/neu co-expression in invasive bladder cancer 2005 ·International Journal of Oncology ·Elke Eltze, Christian Wülfing, (unknown), Hansjürgen Piechota, Horst Buerger, L. Hertle	46
20	Cyclooxygenase-2-Expression beim Harnblasenkarzinom: Tumorbiologische und klinische Bedeutung 2004 ·Aktuelle Urologie ·Christian Wülfing, Elke Eltze, (unknown), P Wülfing, (unknown), Olaf Bettendorf, (unknown), L. Hertle	5

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact